• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症中维生素D的代谢失活增强。

Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism.

作者信息

Clements M R, Davies M, Fraser D R, Lumb G A, Mawer E B, Adams P H

机构信息

University Department of Medicine, Royal Infirmary, Manchester, U.K.

出版信息

Clin Sci (Lond). 1987 Dec;73(6):659-64. doi: 10.1042/cs0730659.

DOI:10.1042/cs0730659
PMID:3690980
Abstract
  1. The elimination half-time of 25-hydroxyvitamin D in plasma was estimated after intravenous injection of the radioactively labelled metabolite in seven patients with primary hyperparathyroidism before and after excision of a parathyroid adenoma. 2. The elimination half-time of 25-hydroxyvitamin D was significantly shortened in primary hyperparathyroidism and reverted towards normal after parathyroidectomy. 3. The increased metabolic clearance of 25-hydroxyvitamin D in primary hyperparathyroidism was accounted for by an increased excretion of vitamin D-derived inactivation products in the faeces. 4. Enhanced hepatic inactivation of 25-hydroxyvitamin D may be important in the development of vitamin D deficiency in primary hyperparathyroidism.
摘要
  1. 在7例原发性甲状旁腺功能亢进患者切除甲状旁腺腺瘤前后,静脉注射放射性标记的代谢产物后,估计血浆中25-羟基维生素D的消除半衰期。2. 原发性甲状旁腺功能亢进时25-羟基维生素D的消除半衰期显著缩短,甲状旁腺切除术后恢复正常。3. 原发性甲状旁腺功能亢进时25-羟基维生素D代谢清除率增加是由于粪便中维生素D衍生的失活产物排泄增加所致。4. 25-羟基维生素D肝脏失活增强可能在原发性甲状旁腺功能亢进维生素D缺乏的发生中起重要作用。

相似文献

1
Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中维生素D的代谢失活增强。
Clin Sci (Lond). 1987 Dec;73(6):659-64. doi: 10.1042/cs0730659.
2
The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency.1,25-二羟基维生素D在获得性维生素D缺乏机制中的作用。
Clin Endocrinol (Oxf). 1992 Jul;37(1):17-27. doi: 10.1111/j.1365-2265.1992.tb02278.x.
3
Changes of urinary cyclic AMP excretion and plasma parathyroid hormone levels before and after parathyroidectomy in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进患者甲状旁腺切除术前、后尿中环磷酸腺苷排泄量及血浆甲状旁腺激素水平的变化
Clin Endocrinol (Oxf). 1979 Sep;11(3):307-12. doi: 10.1111/j.1365-2265.1979.tb03079.x.
4
The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.维生素D缺乏地区维生素D状态对骨病严重程度及原发性甲状旁腺功能亢进症(pHPT)其他特征的影响。
J Endocrinol Invest. 2004 Oct;27(9):807-12. doi: 10.1007/BF03346273.
5
Elevated serum parathyroid hormone concentration in eucalcemic patients after parathyroidectomy for primary hyperparathyroidism and its relationship to vitamin D profile.原发性甲状旁腺功能亢进症患者甲状旁腺切除术后血钙正常患者的血清甲状旁腺激素浓度升高及其与维生素D水平的关系
Metabolism. 2004 Sep;53(9):1101-6. doi: 10.1016/j.metabol.2004.04.003.
6
Vitamin D status in primary hyperparathyroidism in India.印度原发性甲状旁腺功能亢进症患者的维生素D状况
Clin Endocrinol (Oxf). 1995 Sep;43(3):351-8. doi: 10.1111/j.1365-2265.1995.tb02043.x.
7
Serum vitamin D metabolite concentrations in primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者血清维生素D代谢产物浓度
Ann Med. 1989 Aug;21(4):281-3. doi: 10.3109/07853898909149207.
8
Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.影响γ探针引导下甲状旁腺切除术的临床病理和放射药代动力学因素。
Arch Surg. 2004 Nov;139(11):1175-9. doi: 10.1001/archsurg.139.11.1175.
9
Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.通过免疫学和生物学研究判断原发性甲状旁腺功能亢进患者甲状旁腺激素的外周代谢
Eur Surg Res. 1984;16 Suppl 2:41-54. doi: 10.1159/000128621.
10
Persistently elevated parathyroid hormone levels after parathyroid surgery.甲状旁腺手术后甲状旁腺激素水平持续升高。
Surgery. 2005 Dec;138(6):1130-5; discussion 1135-6. doi: 10.1016/j.surg.2005.08.026.

引用本文的文献

1
Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism.意大利散发性原发性甲状旁腺功能亢进症管理指南的微观成本分析
Glob Reg Health Technol Assess. 2025 Jul 25;12:186-193. doi: 10.33393/grhta.2025.3531. eCollection 2025 Jan-Dec.
2
Risk of Malignant Neoplasm in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.原发性甲状旁腺功能亢进症患者恶性肿瘤风险:系统评价和荟萃分析。
Calcif Tissue Int. 2024 Jul;115(1):1-13. doi: 10.1007/s00223-024-01219-y. Epub 2024 May 21.
3
Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism.
意大利散发性原发性甲状旁腺功能亢进症管理指南。
Endocr Metab Immune Disord Drug Targets. 2024;24(8):991-1006. doi: 10.2174/0118715303260423231122111705.
4
Vitamin D Deficiency and the Presentation of Primary Hyperparathyroidism: A Mini Review.维生素D缺乏与原发性甲状旁腺功能亢进的表现:一篇综述
Int J Endocrinol. 2023 Dec 11;2023:1169249. doi: 10.1155/2023/1169249. eCollection 2023.
5
Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis.维生素 D 缺乏对 cyclin D1 诱导甲状旁腺肿瘤发生的影响。
Endocrinology. 2023 Sep 23;164(11). doi: 10.1210/endocr/bqad137.
6
Differences in the Clinical Presentation and Biochemical Profile of the Patients with Primary Hyperparathyroidism with regard to their Serum Vitamin D Levels: a Single-center Experience.原发性甲状旁腺功能亢进患者血清维生素D水平在临床表现和生化指标方面的差异:单中心经验
Indian J Surg Oncol. 2023 Jun;14(2):301-307. doi: 10.1007/s13193-022-01676-7. Epub 2022 Oct 29.
7
Analysis of the cause and management of persistent laboratory abnormalities occurring after the surgical treatment of primary hyperparathyroidism.原发性甲状旁腺功能亢进症手术治疗后持续性实验室异常的原因分析及处理
Ann Surg Treat Res. 2022 Jul;103(1):12-18. doi: 10.4174/astr.2022.103.1.12. Epub 2022 Jul 7.
8
Hungry bone syndrome like presentation following single-dose denosumab for hypercalcaemia secondary to sarcoidosis with IgA nephropathy.继发于 IgA 肾病的结节病高钙血症患者单次使用地舒单抗后出现饥饿骨综合征样表现。
BMJ Case Rep. 2022 Jul 8;15(7):e250647. doi: 10.1136/bcr-2022-250647.
9
Vitamin D and Skeletal Muscle: Current Concepts From Preclinical Studies.维生素D与骨骼肌:临床前研究的当前概念
JBMR Plus. 2021 Nov 15;5(12):e10575. doi: 10.1002/jbm4.10575. eCollection 2021 Dec.
10
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?维生素 D:剂量、水平、形式和给药途径:一种方法适合所有人吗?
Rev Endocr Metab Disord. 2021 Dec;22(4):1201-1218. doi: 10.1007/s11154-021-09693-7. Epub 2021 Dec 23.